These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11144542)

  • 41. Screening for mild thyroid failure.
    Wadland WC
    J Fam Pract; 1996 Nov; 43(5):441-2. PubMed ID: 8917141
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results of observation of persons with increased sensitivity to standard tuberculin].
    Tabidze ShA
    Probl Tuberk; 1970; 48(12):15-9. PubMed ID: 5516179
    [No Abstract]   [Full Text] [Related]  

  • 43. A cost-benefit study of a hypertension screening and treatment program at the work setting.
    Hannan EL; Graham JK
    Inquiry; 1978 Dec; 15(4):345-48. PubMed ID: 152293
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness analysis of strategies for screening prostatic cancer.
    Launois R
    Dev Health Econ Public Policy; 1992; 1():81-108. PubMed ID: 10151755
    [No Abstract]   [Full Text] [Related]  

  • 45. The opportunity costs of screening children for asthma.
    McElligott S; Polsky D
    J Allergy Clin Immunol; 2010 Mar; 125(3):651-2. PubMed ID: 20226299
    [No Abstract]   [Full Text] [Related]  

  • 46. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.
    Marks SM; Dowdy DW; Menzies NA; Shete PB; Salomon JA; Parriott A; Shrestha S; Flood J; Hill AN
    Public Health Rep; 2020; 135(1_suppl):38S-43S. PubMed ID: 32735183
    [No Abstract]   [Full Text] [Related]  

  • 47. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis.
    Verguet S; Laxminarayan R; Jamison DT
    Health Econ; 2015 Mar; 24(3):318-32. PubMed ID: 24497185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of childhood tuberculosis.
    Amdekar YK
    Indian Pediatr; 1998 May; 35(5):491-3. PubMed ID: 10216642
    [No Abstract]   [Full Text] [Related]  

  • 49. [The problem of tuberculosis at present].
    Ursov IG
    Sov Med; 1990; (11):3-7. PubMed ID: 2075519
    [No Abstract]   [Full Text] [Related]  

  • 50. American Thoracic Society-Center for Disease Control. Toward eradication--a contemporary tuberculosis control strategy.
    Am Rev Respir Dis; 1978 Sep; 118(3):641-4. PubMed ID: 707888
    [No Abstract]   [Full Text] [Related]  

  • 51. Analytical models in economic evaluation studies.
    Silva EN; Silva MT; Pereira MG
    Epidemiol Serv Saude; 2016; 25(4):855-858. PubMed ID: 27869980
    [No Abstract]   [Full Text] [Related]  

  • 52. A normative analytic framework for development of practice guidelines for specific clinical populations.
    Owens DK; Nease RF
    Med Decis Making; 1997; 17(4):409-26. PubMed ID: 9343799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness of intravenous chemohormonotherapy of tuberculosis].
    Stamboltsian LP
    Probl Tuberk; 1969; 47(11):20-3. PubMed ID: 5369221
    [No Abstract]   [Full Text] [Related]  

  • 54. [Preventive chemotherapy in protection against tuberculosis].
    Fréour P; Coudray P
    J Med Bord; 1965 May; 142(5):821-45. PubMed ID: 5830452
    [No Abstract]   [Full Text] [Related]  

  • 55. Preoperative hemostatic screening for pediatric adenotonsillar surgery: worthwhile effort or waste of resources?
    Werner EJ
    Pediatr Blood Cancer; 2010 Dec; 55(6):1045-6. PubMed ID: 20979166
    [No Abstract]   [Full Text] [Related]  

  • 56. [New infrastructures in the system of organization of antituberculosis services].
    Polivakho VV; Strelis AK; Sharaburova OE; Ianova GV; Golubchikova VT; Eĭrikh IM; Chukova NV
    Probl Tuberk; 1999; (5):8-9. PubMed ID: 10565205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Would pan-tuberculosis treatment regimens be cost-effective?
    Kendall EA; Brigden G; Lienhardt C; Dowdy DW
    Lancet Respir Med; 2018 Jul; 6(7):486-488. PubMed ID: 29859919
    [No Abstract]   [Full Text] [Related]  

  • 58. Valuing vision.
    Kemper AR
    Pediatrics; 2004 Feb; 113(2):404-5. PubMed ID: 14754958
    [No Abstract]   [Full Text] [Related]  

  • 59. Summaries for patients. The cost-effectiveness of screening for type 2 diabetes.
    Ann Intern Med; 2004 May; 140(9):I29. PubMed ID: 15126270
    [No Abstract]   [Full Text] [Related]  

  • 60. Should we screen for type 2 diabetes: Yes.
    Khunti K; Davies M
    BMJ; 2012 Jul; 345():e4514. PubMed ID: 22777029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.